Literature DB >> 7869049

Multi-colony stimulating activity of interleukin 5 (IL-5) on hematopoietic progenitors from transgenic mice that express IL-5 receptor alpha subunit constitutively.

M Takagi1, T Hara, M Ichihara, K Takatsu, A Miyajima.   

Abstract

The interleukin 3 (IL-3), IL-5, and granulocyte/macrophage colony-stimulating factor receptors consist of a cytokine-specific alpha subunit and the common beta subunit. Whereas IL-3 stimulates various lineages of hematopoietic cells, including multipotential progenitors, IL-5 acts mainly as an eosinophil lineage-specific factor. To investigate whether the lineage specificity of IL-5 is due to restricted expression of the IL-5 receptor alpha subunit (IL-5R alpha), we generated transgenic mice that express the mouse IL-5R alpha constitutively by phosphoglycerate kinase promoter. The transgenic mouse expressed IL-5R alpha ubiquitously, and the bone marrow cells formed various types of colonies, including multi-lineage colonies, in response to IL-5. IL-5 also supported formation of both multi-lineage and blast cell colonies from dormant progenitors of the 5-fluorouracil-treated transgenic mice. The cells composing the blast cell colony gave rise to many colonies including multi-lineage colonies when they were replated in secondary culture containing either Il-5 or IL-3. There was no significant difference in replating efficiency or in types of secondary colonies between IL-5- and IL-3-stimulated cultures. Conversely, the cells from the IL-3-induced blast cell colonies of the transgenic mice proliferated in response to either IL-3 or IL-5. Thus, the development of the progenitors can be equally supported by either IL-5 or IL-3, suggesting that intracellular signals from the IL-3R can be replaced by those from IL-5. These results strongly suggest that the lineage specificity of IL-5 is mainly due to the restricted expression of IL-5R alpha.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869049      PMCID: PMC2191903          DOI: 10.1084/jem.181.3.889

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Use of the silkworm, Bombyx mori, and an insect baculovirus vector for high-level expression and secretion of biologically active mouse interleukin-3.

Authors:  A Miyajima; J Schreurs; K Otsu; A Kondo; K Arai; S Maeda
Journal:  Gene       Date:  1987       Impact factor: 3.688

Review 2.  Cytokines: coordinators of immune and inflammatory responses.

Authors:  K I Arai; F Lee; A Miyajima; S Miyatake; N Arai; T Yokota
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

3.  Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family.

Authors:  N Itoh; S Yonehara; J Schreurs; D M Gorman; K Maruyama; A Ishii; I Yahara; K Arai; A Miyajima
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

4.  Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell?

Authors:  G S Hodgson; T R Bradley
Journal:  Nature       Date:  1979-10-04       Impact factor: 49.962

5.  Erythroid burst-promoting activity of purified recombinant human GM-CSF and interleukin-3: studies with anti-GM-CSF and anti-IL-3 sera and studies in serum-free cultures.

Authors:  Y Sonoda; Y C Yang; G G Wong; S C Clark; M Ogawa
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

6.  Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells.

Authors:  Y Hitoshi; N Yamaguchi; S Mita; E Sonoda; S Takaki; A Tominaga; K Takatsu
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

7.  Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family.

Authors:  D M Gorman; N Itoh; T Kitamura; J Schreurs; S Yonehara; I Yahara; K Arai; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 8.  T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties.

Authors:  K Takatsu; A Tominaga; N Harada; S Mita; M Matsumoto; T Takahashi; Y Kikuchi; N Yamaguchi
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

9.  Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter.

Authors:  C N Adra; P H Boer; M W McBurney
Journal:  Gene       Date:  1987       Impact factor: 3.688

10.  Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture.

Authors:  K Koike; T Nakahata; M Takagi; T Kobayashi; A Ishiguro; K Tsuji; K Naganuma; A Okano; Y Akiyama; T Akabane
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  9 in total

1.  Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains.

Authors:  A Iwama; J Pan; P Zhang; W Reith; B Mach; D G Tenen; Z Sun
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

2.  Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.

Authors:  M Takagi; T Nakamura; T Sawada; A Kaneko; M Nozaki-Ukai; T Nakahata; T Yokota; T Heike
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

3.  Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice.

Authors:  R J D'Andrea; D Harrison-Findik; C M Butcher; J Finnie; P Blumbergs; P Bartley; M McCormack; K Jones; R Rowland; T J Gonda; M A Vadas
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

4.  Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis.

Authors:  Carine Bouffi; Andrey V Kartashov; Kaila L Schollaert; Xiaoting Chen; W Clark Bacon; Matthew T Weirauch; Artem Barski; Patricia C Fulkerson
Journal:  J Immunol       Date:  2015-08-12       Impact factor: 5.422

5.  Identification of eosinophil lineage-committed progenitors in the murine bone marrow.

Authors:  Hiromi Iwasaki; Shin-ichi Mizuno; Robin Mayfield; Hirokazu Shigematsu; Yojiro Arinobu; Brian Seed; Michael F Gurish; Kiyoshi Takatsu; Koichi Akashi
Journal:  J Exp Med       Date:  2005-06-13       Impact factor: 14.307

6.  Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.

Authors:  Hitoshi Suzuki; Milan Raska; Koshi Yamada; Zina Moldoveanu; Bruce A Julian; Robert J Wyatt; Yasuhiko Tomino; Ali G Gharavi; Jan Novak
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

7.  Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion.

Authors:  Junko Iwasaki-Arai; Hiromi Iwasaki; Toshihiro Miyamoto; Sumiko Watanabe; Koichi Akashi
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

8.  Quantitative real time polymerase chain reaction for measurement of human interleukin-5 receptor alpha spliced isoforms mRNA.

Authors:  Claudina Pérez; Jo Vandesompele; Ina Vandenbroucke; Gabriele Holtappels; Frank Speleman; Philippe Gevaert; Paul Van Cauwenberge; Claus Bachert
Journal:  BMC Biotechnol       Date:  2003-09-30       Impact factor: 2.563

Review 9.  The clinical profile of benralizumab in the management of severe eosinophilic asthma.

Authors:  Francesco Menzella; Mirco Lusuardi; Carla Galeone; Nicola Facciolongo; Luigi Zucchi
Journal:  Ther Adv Respir Dis       Date:  2016-09-09       Impact factor: 4.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.